BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 6357823)

  • 1. Myocardial infarction in women.
    Johansson S; Vedin A; Wilhelmsson C
    Epidemiol Rev; 1983; 5():67-95. PubMed ID: 6357823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and myocardial infarction.
    Petitti DB; Sidney S; Quesenberry CP
    Contraception; 1998 Mar; 57(3):143-55. PubMed ID: 9617531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the epidemiology of oral contraceptives and disease.
    Prentice RL; Thomas DB
    Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive Steroids, age, and the cardiovascular system.
    Plunkett ER
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol, lipoproteins, and coronary heart disease in women.
    Bush TL; Fried LP; Barrett-Connor E
    Clin Chem; 1988; 34(8B):B60-70. PubMed ID: 3042201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogens and progestogens on lipid metabolism.
    Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and vascular disease.
    Sartwell PE; Stolley PD
    Epidemiol Rev; 1982; 4():95-109. PubMed ID: 6754411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of correlation between oral contraceptive usage and cardiovascular mortality.
    Wiseman RA
    Int J Fertil; 1984; 29(4):198-208. PubMed ID: 6152441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormones and cardiovascular risk.
    La Vecchia C
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for coronary heart disease in women.
    Hennekens CH
    Cardiol Clin; 1998 Feb; 16(1):1-8. PubMed ID: 9507775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of oral contraceptives and cardiovascular disease.
    Chasan-Taber L; Stampfer MJ
    Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral contraceptives and serum beta-carotene.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1997 Mar; 51(3):181-7. PubMed ID: 9076409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.
    Thorogood M; Vessey MP
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):274-81. PubMed ID: 2196799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two problems in oral contraception: arteriosclerotic cardiopathy and drug interactions.
    Onnis A; Grella PV; Di Lenardo L
    Clin Exp Obstet Gynecol; 1982; 9(2):61-5. PubMed ID: 7160061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.